Related Experiment Video
Updated: Nov 16, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Renal Denervation: A Revival or The Same Old Story
Travis Chong1, Michael Nguyen2
1Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia.
Renal denervation offers a promising alternative for hypertension management beyond medication. Recent trials show renewed interest in this minimally invasive approach for blood pressure control.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Hypertension remains a leading cause of noncommunicable deaths and cardiovascular disease.
- Pharmacological treatments are standard but face challenges with disease burden.
- Innovative approaches for blood pressure control are increasingly important.
Purpose of the Study:
- To evaluate the renewed clinical interest in renal denervation for hypertension treatment.
- To assess the efficacy of catheter-based renal sympathetic nerve ablation.
Main Methods:
- Review of recent second-generation clinical trials on renal denervation.
- Analysis of minimally invasive catheter-based ablation systems targeting renal nerves.
Main Results:
- Clinical data for renal denervation has shown historical variability.
- Recent second-generation trials demonstrate promising results.
Conclusions:
- Renal denervation is regaining interest as a treatment for hypertension.
- This minimally invasive approach offers a potential alternative for blood pressure control.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Acute Kidney Injury II: Pathophysiology
Heart Failure Drugs: Diuretics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...